# Human Penile Allotransplantation

> **NCT02395497** · PHASE2,PHASE3 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 60 (estimated)

## Conditions studied

- Amputation
- Wounds and Injuries
- Amputation, Traumatic
- Urologic Surgical Procedures, Male
- Amputation, Traumatic/Surgery
- Penis/Transplantation
- Penis/Surgery
- Penis/Injuries
- Congenital Anomaly, Male Genitalia

## Interventions

- **BIOLOGICAL:** Monoclonal Antibody (Humanized Anti-CD52)
- **DRUG:** Tacrolimus
- **PROCEDURE:** Penile Allotransplantation

## Key facts

- **NCT ID:** NCT02395497
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-06
- **Primary completion:** 2034-06
- **Final completion:** 2039-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02395497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02395497, "Human Penile Allotransplantation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02395497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*